Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 7
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Feedback
Subscribe
 Back To Article

  Reader Comments

Year : 2020 | Volume:  9 | Issue Number:  7

ORIGINAL ARTICLE

Cost-utility analysis of Macitentan Vs. Bosentan in pulmonary atrial hypertension

Nosrati Marzieh, Shahmirzadi Nikinaz Ashrafi, Afzali Monireh, Zaboli Pardis, Rouhani Hasti, Hamedifar Haleh, Hajimiri Mirhamed

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks